DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Voit T, Topaloglu H, Straub V , et al.
Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study.
Lancet Neurol 2014;
13 (10) 987-996
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.